35 results on '"McCarthy, James"'
Search Results
2. Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection.
- Author
-
Collins, Katharine A, Abd-Rahman, Azrin N, Marquart, Louise, Ballard, Emma, Gobeau, Nathalie, Griffin, Paul, Chalon, Stephan, Möhrle, Jörg J, and McCarthy, James S
- Subjects
PLASMODIUM vivax ,CLINICAL trial registries ,GERM cells ,PARASITES ,MALARIA prevention ,TRYPANOSOMA cruzi ,TRYPANOSOMA ,DRUG therapy for malaria ,FOLIC acid antagonists ,PROTOZOA ,RESEARCH ,ANIMAL experimentation ,RESEARCH methodology ,EVALUATION research ,MALARIA ,HYDROCARBONS ,PEROXIDES ,COMPARATIVE studies ,RESEARCH funding ,ANTIMALARIALS ,MOSQUITOES ,PHARMACODYNAMICS - Abstract
Background: Interventions that effectively target Plasmodium vivax are critical for the future control and elimination of malaria. We conducted a P. vivax volunteer infection study to characterize the antimalarial activity of artefenomel, a new drug candidate.Methods: Eight healthy, malaria-naive participants were intravenously inoculated with blood-stage P. vivax and subsequently received a single oral 200-mg dose of artefenomel. Blood samples were collected to monitor the development and clearance of parasitemia, and plasma artefenomel concentration. Mosquito feeding assays were conducted before artefenomel dosing to investigate parasite transmissibility.Results: Initial parasite clearance occurred in all participants after artefenomel administration (log10 parasite reduction ratio over 48 hours, 1.67; parasite clearance half-life, 8.67 hours). Recrudescence occurred in 7 participants 11-14 days after dosing. A minimum inhibitory concentration of 0.62 ng/mL and minimum parasiticidal concentration that achieves 90% of maximum effect of 0.83 ng/mL were estimated, and a single 300-mg dose was predicted to clear 109 parasites per milliliter with 95% certainty. Gametocytemia developed in all participants and was cleared 4-8 days after dosing. At peak gametocytemia, 75% of participants were infectious to mosquitoes.Conclusions: The in vivo antimalarial activity of artefenomel supports its further clinical development as a treatment for P. vivax malaria.Clinical Trials Registration: NCT02573857. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
3. Effect of antimalarial drugs on plasmodium falciparum gametocytes
- Author
-
Peatey, Christopher L., Skinner-Adams, Tina S., Dixon, Matthew W.A., McCarthy, James S., Gardiner, Donald L., and Trenholme, Katharine R.
- Subjects
Plasmodium falciparum -- Drug therapy ,Plasmodium falciparum -- Health aspects ,Antimalarials -- Usage ,Antimalarials -- Health aspects ,Gametocytes -- Research ,Gametocytes -- Physiological aspects ,Health - Published
- 2009
4. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests
- Author
-
Baker, Joanne, McCarthy, James, Gatton, Michelle, Kyle, Dennis E., Belizario, Vicente, Luchavez, Jennifer, Bell, David, and Cheng, Qin
- Subjects
Medical care, Cost of -- Statistics ,Malaria -- Diagnosis ,Malaria -- Drug therapy ,Health - Published
- 2005
5. Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite–Induced Controlled Malaria Infection.
- Author
-
Alkema, Manon, Reuling, Isaie J, Jong, Gerdie M de, Lanke, Kjerstin, Coffeng, Luc E, Gemert, Geert-Jan van, van de Vegte-Bolmer, Marga, Mast, Quirijn de, Crevel, Reinout van, Ivinson, Karen, Ockenhouse, Christian F, McCarthy, James S, Sauerwein, Robert, Collins, Katharine A, and Bousema, Teun
- Subjects
MALARIA prevention ,CLINICAL trials ,PLASMODIUM falciparum ,MOSQUITO control ,INFECTION control ,MOSQUITO nets - Abstract
Background For malaria elimination efforts, it is important to better understand parasite transmission to mosquitoes and develop models for early-clinical evaluation of transmission-blocking interventions. Methods In a randomized open-label trial, 24 participants were infected by bites from Plasmodium falciparum 3D7-infected mosquitoes (mosquito bite [MB]; n = 12) or by induced blood-stage malaria (IBSM) with the same parasite line (n = 12). After subcurative piperaquine treatment, asexual parasite and gametocytes kinetics were assessed, and mosquito feeding experiments were performed. Results Study procedures were well tolerated. The median peak gametocyte density was 1304/mL (interquartile range, 308–1607/mL) after IBSM, compared with 14/mL (10–64/mL) after MB inoculation (P < .001), despite similar peak asexual parasite densities (P = .48). Peak gametocyte density was correlated with preceding pfap2-g transcripts, indicative of gametocyte commitment (ρ = 0.62; P = .002). Direct feeding assays resulted in mosquito infections from 9 of 12 participants after IBSM versus 0 of 12 after MB inoculation (P < .001). Conclusions We observed a striking effect of inoculation method on gametocyte production, suggesting higher gametocyte commitment after IBSM. Our direct comparison of MB and IBSM establishes the controlled human malaria infection transmission model, using intravenous administration of P. falciparum –infected erythrocytes as a model for early-clinical evaluation of interventions that aim to interrupt malaria transmission. Clinical Trial Registration NCT03454048 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans.
- Author
-
Rebelo, Maria, Pawliw, Rebecca, Gower, Jeremy, Webb, Lachlan, Mitchell, Hayley, Pava, Zuleima, Watts, Rebecca E, Davenport, Miles P, McCarthy, James S, and Khoury, David S
- Subjects
ARTEMISININ derivatives ,BLOOD parasites ,POLYMERASE chain reaction ,PARASITES ,TRYPANOSOMA cruzi ,PLASMODIUM falciparum ,DRUG therapy for malaria ,PROTOZOA ,RESEARCH ,MATHEMATICAL models ,RESEARCH methodology ,DRUG resistance ,EVALUATION research ,COMPARATIVE studies ,THEORY ,ANTIMALARIALS - Abstract
Background: Artemisinin derivatives are the leading class of antimalarial drugs due to their rapid onset of action and rapid clearance of circulating parasites. The parasite clearance half-life measures the rate of loss of parasites from blood after treatment, and this is currently used to assess antimalarial activity of novel agents and to monitor resistance. However, a number of recent studies have challenged the use of parasite clearance to measure drug activity, arguing that many circulating parasites may be nonviable.Methods: Plasmodium falciparum-infected subjects (n = 10) in a malaria volunteer infection study were administered a single dose of artesunate (2 mg/kg). Circulating parasite concentration was assessed by means of quantitative polymerase chain reaction (qPCR). Parasite viability after artesunate administration was estimated by mathematical modeling of the ex vivo growth of parasites collected from subjects.Results: We showed that in artemisinin-sensitive infection, viable parasites declined to <0.1% of baseline within 8 hours after artesunate administration, while the total number of circulating parasites measured with quantitative polymerase chain reaction remained unchanged. In artemisinin-resistant infections over the same interval, viable parasites declined to 51.4% (standard error of the mean, 4.6%) of baseline.Conclusions: These results demonstrate that in vivo drug activity of artesunate is faster than is indicated by the parasite clearance half-life. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
7. Dormant Plasmodium falciparum Parasites in Human Infections Following Artesunate Therapy.
- Author
-
Peatey, Christopher, Chen, Nanhua, Gresty, Karryn, Anderson, Karen, Pickering, Paul, Watts, Rebecca, Gatton, Michelle L, McCarthy, James, and Cheng, Qin
- Subjects
PLASMODIUM falciparum ,GENETIC mutation ,PARASITES ,ARTEMISININ ,BLOOD sampling - Abstract
Background: Artemisinin monotherapy of Plasmodium falciparum infection is frequently ineffective due to recrudescence. Artemisinin-induced dormancy, shown in vitro and in animal models, provides a plausible explanation. To date, direct evidence of artemisinin-induced dormancy in humans is lacking.Methods: Blood samples were collected from Plasmodium falciparum 3D7- or K13-infected participants before and 48-72 hours after single-dose artesunate (AS) treatment. Parasite morphology, molecular signature of dormancy, capability and dynamics of seeding in vitro cultures, and genetic mutations in the K13 gene were investigated.Results: Dormant parasites were observed in post-AS blood samples of 3D7- and K13-infected participants. The molecular signature of dormancy, an up-regulation of acetyl CoA carboxylase, was detected in 3D7 and K13 samples post-AS, but not in pre-AS samples. Posttreatment samples successfully seeded in vitro cultures, with a significant delay in time to reach 2% parasitemia compared to pretreatment samples.Conclusions: This study provides strong evidence for the presence of artemisinin-induced dormant parasites in P. falciparum infections. These parasites are a likely reservoir for recrudescent infection following artemisinin monotherapy and artemisinin combination therapy (ACT). Combination regimens that target dormant parasites or remain at therapeutic levels for a sufficient time to kill recovering parasites will likely improve efficacy of ACTs. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data From Malaria Volunteer Infection Studies.
- Author
-
Wockner, Leesa F, Hoffmann, Isabell, Webb, Lachlan, Mordmüller, Benjamin, Murphy, Sean C, Kublin, James G, O'Rourke, Peter, McCarthy, James S, and Marquart, Louise
- Subjects
PLASMODIUM falciparum ,MALARIA ,BLOOD parasites ,PLASMODIUM ,PROTOZOA ,RESEARCH ,PARASITEMIA ,RESEARCH methodology ,RETROSPECTIVE studies ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies - Abstract
Background: Growth rate of malaria parasites in the blood of infected subjects is an important measure of efficacy of drugs and vaccines.Methods: We used log-linear and sine-wave models to estimate the parasite growth rate of the 3D7 strain of Plasmodium falciparum using data from 177 subjects from 14 induced blood stage malaria (IBSM) studies conducted at QIMR Berghofer. We estimated parasite multiplication rate per 48 hours (PMR48), PMR per life-cycle (PMRLC), and parasite life-cycle duration. We compared these parameters to those from studies conducted elsewhere with infections induced by IBSM (n = 66), sporozoites via mosquito bite (n = 336), or injection (n = 51).Results: The parasite growth rate of 3D7 in QIMR Berghofer studies was 0.75/day (95% confidence interval [CI], .73-.77/day), PMR48 was 31.9 (95% CI, 28.7-35.4), PMRLC was 16.4 (95% CI, 15.1-17.8), and parasite life-cycle was 38.8 hours (95% CI, 38.3-39.2 hours). These parameters were similar to estimates from IBSM studies elsewhere (0.71/day, 95% CI, .67-.75/day; PMR48 26.6, 95% CI, 22.2-31.8) but significantly higher (P < .001) than in sporozoite studies (0.47/day, 95% CI, .43-.50/day; PMR48 8.6, 95% CI, 7.3-10.1).Conclusions: Parasite growth rates were similar across different IBSM studies and higher than infections induced by sporozoite. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
9. An Experimental Human Blood-Stage Model for Studying Plasmodium malariae Infection.
- Author
-
Woodford, John, Collins, Katharine A, Odedra, Anand, Wang, Claire, Jang, Ihn Kyung, Domingo, Gonzalo J, Watts, Rebecca, Marquart, Louise, Berriman, Matthew, Otto, Thomas D, and McCarthy, James S
- Subjects
PLASMODIUM ,SYMPTOMS ,PARASITEMIA ,INFECTION ,MALARIA ,PROTOZOA physiology ,PROTOZOA ,FOOD habits ,RESEARCH ,ANIMAL experimentation ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies ,GENE expression profiling ,ANTIMALARIALS ,INSECTS - Abstract
Background: Plasmodium malariae is considered a minor malaria parasite, although its global disease burden is underappreciated. The aim of this study was to develop an induced blood-stage malaria (IBSM) model of P. malariae to study parasite biology, diagnostic assays, and treatment.Methods: This clinical trial involved 2 healthy subjects who were intravenously inoculated with cryopreserved P. malariae-infected erythrocytes. Subjects were treated with artemether-lumefantrine after development of clinical symptoms. Prior to antimalarial therapy, mosquito-feeding assays were performed to investigate transmission, and blood samples were collected for rapid diagnostic testing and parasite transcription profiling. Serial blood samples were collected for biomarker analysis.Results: Both subjects experienced symptoms and signs typical of early malaria. Parasitemia was detected 7 days after inoculation, and parasite concentrations increased until antimalarial treatment was initiated 25 and 21 days after inoculation for subjects 1 and 2 respectively (peak parasitemia levels, 174 182 and 50 291 parasites/mL, respectively). The parasite clearance half-life following artemether-lumefantrine treatment was 6.7 hours. Mosquito transmission was observed for 1 subject, while in vivo parasite transcription and biomarkers were successfully profiled.Conclusions: An IBSM model of P. malariae has been successfully developed and may be used to study the biology of, diagnostic testing for, and treatment of this neglected malaria species.Clinical Trials Registration: ACTRN12617000048381. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
10. Antiphosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associated With Early Anemia in Both Species.
- Author
-
Barber, Bridget E, Grigg, Matthew J, Piera, Kim, Amante, Fiona H, William, Timothy, Boyle, Michelle J, Minigo, Gabriela, Dondorp, Arjen M, McCarthy, James S, and Anstey, Nicholas M
- Subjects
IMMUNOGLOBULIN M ,IMMUNOGLOBULIN G ,TRYPANOSOMA ,MALARIA ,IMMUNOGLOBULINS ,ERYTHROCYTES ,PHAGOCYTOSIS ,ANTICARDIOLIPIN antibodies ,ANEMIA ,AUTOANTIBODIES ,COMPARATIVE studies ,HEMOGLOBINS ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,EVALUATION research ,DISEASE complications - Abstract
Background: Anemia is a major complication of vivax malaria. Antiphosphatidylserine (PS) antibodies generated during falciparum malaria mediate phagocytosis of uninfected red blood cells that expose PS and have been linked to late malarial anemia. However, their role in anemia from non-falciparum Plasmodium species is not known, nor their role in early anemia from falciparum malaria.Methods: We measured PS immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in Malaysian patients with vivax, falciparum, knowlesi, and malariae malaria, and in healthy controls, and correlated antibody titres with hemoglobin. PS antibodies were also measured in volunteers experimentally infected with Plasmodium vivax and Plasmodium falciparum.Results: PS IgM and IgG antibodies were elevated in patients with vivax, falciparum, knowlesi, and malariae malaria (P < .0001 for all comparisons with controls) and were highest in vivax malaria. In vivax and falciparum malaria, PS IgM and IgG on admission correlated inversely with admission and nadir hemoglobin, controlling for parasitemia and fever duration. PS IgM and IgG were also increased in volunteers infected with blood-stage P. vivax and P. falciparum, and were higher in P. vivax infection.Conclusions: PS antibodies are higher in vivax than falciparum malaria, correlate inversely with hemoglobin, and may contribute to the early loss of uninfected red blood cells found in malarial anemia from both species. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
11. Antiretrovirals as antimalarial agents
- Author
-
Skinner-Adams, Tina S., McCarthy, James S., Gardiner, Donald L., Hilton, Petrina M., and Andrews, Katherine T.
- Subjects
Malaria -- Drug therapy ,Antimalarials -- Dosage and administration ,Antiviral agents -- Dosage and administration ,Health - Published
- 2004
12. Plasmodium falciparum Activates CD16 + Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.
- Author
-
Loughland, Jessica R, Woodberry, Tonia, Boyle, Michelle J, Tipping, Peta E, Piera, Kim A, Amante, Fiona H, Kenangalem, Enny, Price, Ric N, Engwerda, Christian R, Anstey, Nicholas M, McCarthy, James S, and Minigo, Gabriela
- Abstract
Background The malaria causing parasite Plasmodium subverts host immune responses by several strategies including the modulation of dendritic cells (DCs). Methods In this study, we show that Plasmodium falciparum skewed CD16
+ DC cytokine responses towards interleukin (IL)-10 production in vitro, distinct to the cytokine profile induced by Toll-like receptor ligation. To determine CD16+ DC responsiveness in vivo, we assessed their function after induced P falciparum infection in malaria-naive volunteers. Results CD16+ DCs underwent distinctive activation, with increased expression of maturation markers human leukocyte antigen (HLA)-DR and CD86, enhanced tumor necrosis factor (TNF) production, and coproduction of TNF/IL-10. In vitro restimulation with P falciparum further increased IL-10 production. In contrast, during naturally acquired malaria episode, CD16+ DCs showed diminished maturation, suggesting increased parasite burden and previous exposure influence DC subset function. Conclusions These findings identify CD16+ DCs as the only DC subset activated during primary blood-stage human Plasmodium infection. As dual cytokine producers, CD16+ DCs contribute to inflammatory as well as regulatory innate immune processes. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
13. Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration
- Author
-
Khoury, David S., primary, Cromer, Deborah, additional, Möhrle, Jörg J., additional, McCarthy, James S., additional, and Davenport, Miles P., additional
- Published
- 2016
- Full Text
- View/download PDF
14. Piperaquine Monotherapy of Drug-SusceptiblePlasmodium falciparumInfection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia
- Author
-
Pasay, Cielo J., primary, Rockett, Rebecca, additional, Sekuloski, Silvana, additional, Griffin, Paul, additional, Marquart, Louise, additional, Peatey, Christopher, additional, Wang, Claire Y. T., additional, O'Rourke, Peter, additional, Elliott, Suzanne, additional, Baker, Mark, additional, Möhrle, Jörg J., additional, and McCarthy, James S., additional
- Published
- 2016
- Full Text
- View/download PDF
15. Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
- Author
-
Payne, Ruth O., primary, Milne, Kathryn H., additional, Elias, Sean C., additional, Edwards, Nick J., additional, Douglas, Alexander D., additional, Brown, Rebecca E., additional, Silk, Sarah E., additional, Biswas, Sumi, additional, Miura, Kazutoyo, additional, Roberts, Rachel, additional, Rampling, Thomas W., additional, Venkatraman, Navin, additional, Hodgson, Susanne H., additional, Labbé, Geneviève M., additional, Halstead, Fenella D., additional, Poulton, Ian D., additional, Nugent, Fay L., additional, de Graaf, Hans, additional, Sukhtankar, Priya, additional, Williams, Nicola C., additional, Ockenhouse, Christian F., additional, Kathcart, April K., additional, Qabar, Aziz N., additional, Waters, Norman C., additional, Soisson, Lorraine A., additional, Birkett, Ashley J., additional, Cooke, Graham S., additional, Faust, Saul N., additional, Woods, Colleen, additional, Ivinson, Karen, additional, McCarthy, James S., additional, Diggs, Carter L., additional, Vekemans, Johan, additional, Long, Carole A., additional, Hill, Adrian V. S., additional, Lawrie, Alison M., additional, Dutta, Sheetij, additional, and Draper, Simon J., additional
- Published
- 2016
- Full Text
- View/download PDF
16. Early Changes in CD4+ T-Cell Activation During Blood-Stage Plasmodium falciparum Infection.
- Author
-
Edwards, Chelsea L, Ng, Susanna S, Corvino, Dillon, Oca, Marcela Montes de, Rivera, Fabian de Labastida, Nones, Katia, Lakis, Vanessa, Waddell, Nicola, Amante, Fiona H, McCarthy, James S, Montes de Oca, Marcela, de Labastida Rivera, Fabian, and Engwerda, Christian R
- Subjects
RISK of malaria ,PLASMODIUM falciparum ,CD4 antigen ,IMMUNOREGULATION ,ARTEMISININ ,MALARIA vaccines ,ANTIPARASITIC agents ,THERAPEUTICS - Abstract
We examined transcriptional changes in CD4+ T cells during blood-stage Plasmodium falciparum infection in individuals without a history of previous parasite exposure. Transcription of CXCL8 (encoding interleukin 8) in CD4+ T cells was identified as an early biomarker of submicroscopic P. falciparum infection, with predictive power for parasite growth. Following antiparasitic drug treatment, a CD4+ T-cell regulatory phenotype developed. PD1 expression on CD49b+CD4+ T (putative type I regulatory T) cells after drug treatment negatively correlated with earlier parasite growth. Blockade of PD1 but no other immune checkpoint molecules tested increased interferon γ and interleukin 10 production in an ex vivo antigen-specific cellular assay at the peak of infection. These results demonstrate the early development of an immunoregulatory CD4+ T-cell phenotype in blood-stage P. falciparum infection and show that a selective immune checkpoint blockade may be used to modulate early developing antiparasitic immunoregulatory pathways as part of malaria vaccine and/or drug treatment protocols. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.
- Author
-
Feng, Gaoqian, Boyle, Michelle J., Cross, Nadia, Chan, Jo-Anne, Reiling, Linda, Osier, Faith, Stanisic, Danielle I., Mueller, Ivo, Anders, Robin F., McCarthy, James S., Richards, Jack S., and Beeson, James G.
- Subjects
MALARIA vaccines ,IMMUNOGLOBULINS ,PLASMODIUM falciparum ,PHAGOCYTOSIS ,MEROZOITES - Abstract
Background: Overcoming antigenic diversity is a key challenge in the development of effective Plasmodium falciparum malaria vaccines. Strategies that promote the generation of antibodies targeting conserved epitopes of vaccine antigens may provide protection against diverse parasites strains. Understanding differences between vaccine-induced and naturally acquired immunity is important to achieving this goal.Methods: We analyzed antibodies generated in a phase 1 human vaccine trial, MSP2-C1, which included 2 allelic forms of MSP2, an abundant vaccine antigen on the merozoite surface. Vaccine-induced responses were assessed for functional activity against multiple parasite strains, and cross-reactivity of antibodies was determined using competition ELISA and epitope mapping approaches.Results: Vaccination induced cytophilic antibody responses with strain-transcending opsonic phagocytosis and complement-fixing function. In contrast to antibodies acquired via natural infection, vaccine-induced antibodies were directed towards conserved epitopes at the C-terminus of MSP2, whereas naturally acquired antibodies mainly targeted polymorphic epitopes. Functional activity of C-terminal-targeted antibodies was confirmed using monoclonal antibodies that promoted opsonic phagocytosis against multiple parasite strains.Conclusion: Vaccination generated markedly different responses to polymorphic antigens than naturally acquired immunity and targeted conserved functional epitopes. Induction of antibodies targeting conserved regions of malaria antigens provides a promising vaccine strategy to overcome antigenic diversity for developing effective malaria vaccines. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
18. Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.
- Author
-
Farid, Ryan, Dixon, Matthew W., Tilley, Leann, and McCarthy, James S.
- Subjects
PLASMODIUM ,BLOOD parasites ,GERM cells ,PARASITEMIA ,PARASITIC diseases - Abstract
The recent focus on the elimination of malaria has led to an increased interest in the role of sexual stages in its transmission. We introduce Plasmodium falciparum gametocyte exported protein-5 (PfGEXP5) transcript analysis as an important tool for evaluating the earliest (ring) stage sexual gametocytes in the blood of infected individuals. We show that gametocyte rings are detected in the peripheral blood immediately following establishment of asexual infections-without the need for triggers such as high-density asexual parasitemia or drug treatment. Committed gametocytes are refractory to the commonly used drug piperaquine, and mature gametocytes reappear in the bloodstream 10 days after the initial appearance of gametocyte rings. A further wave of commitment is observed following recrudescent asexual parasitemia, and these gametocytes are again refractory to piperaquine treatment. This work has implications for monitoring gametocyte and transmission dynamics and responses to drug treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. Posttreatment Transaminase Elevations in Controlled Human Malaria Infection and Naturally Acquired Malaria.
- Author
-
Odedra, Anand, Woodford, John, Chalon, Stephan, Barber, Bridget E, and McCarthy, James S
- Subjects
MALARIA ,INFECTION ,HUMAN beings ,DRUG therapy for malaria ,AMINOTRANSFERASES - Published
- 2022
- Full Text
- View/download PDF
20. Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia.
- Author
-
Pasay, Cielo J., Rockett, Rebecca, Sekuloski, Silvana, Griffin, Paul, Marquart, Louise, Peatey, Christopher, Wang, Claire Y. T., O'Rourke, Peter, Elliott, Suzanne, Baker, Mark, Möhrle, Jörg J., and McCarthy, James S.
- Subjects
ARTEMISININ ,ANTIMALARIALS ,GERM cells ,MALARIA ,SESQUITERPENES - Abstract
Background: Piperaquine, coformulated with dihydroartemisinin, is a component of a widely used artemisinin combination therapy. There is a paucity of data on its antimalarial activity as a single agent. Such data, if available, would inform selection of new coformulations.Methods: We undertook a study in healthy subjects, using the induced blood stage malaria (IBSM) model to test the antimalarial activity of single doses of piperaquine (960, 640, and 480 mg) in 3 cohorts. In a pilot study in the third cohort, gametocyte clearance following administration of 15 mg, or 45 mg or no primaquine was investigated.Results: Parasite clearance over the 48-hour period after piperaquine administration was more rapid in the 960 mg cohort, compared with the 640 mg cohort (parasite reduction ratio, 2951 [95% confidence interval {CI}, 1520-5728] vs 586 [95% CI, 351-978]; P < .001). All 24 subjects developed gametocytemia as determined by pfs25 transcripts. Clearance of pfs25 was significantly faster in those receiving primaquine than in those not receiving primaquine (P < .001).Conclusions: Piperaquine possesses rapid parasite-clearing activity, but monotherapy is followed by the appearance of gametocytemia, which could facilitate the spread of malaria. This new information should be taken into account when developing future antimalarial coformulations.Clinical Trials Registration: ACTRN12613000565741. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
21. Reply to White and Watson.
- Author
-
Rebelo, Maria, McCarthy, James S, and Khoury, David S
- Subjects
- *
PHARMACOKINETICS - Published
- 2021
- Full Text
- View/download PDF
22. Analysis of Breath Specimens for Biomarkers of Plasmodium falciparum Infection.
- Author
-
Berna, Amalia Z., McCarthy, James S., Wang, Rosalind X., Saliba, Kevin J., Bravo, Florence G., Cassells, Julie, Padovan, Benjamin, and Trowell, Stephen C.
- Subjects
- *
MALARIA diagnosis , *ORGANIC compound analysis , *SULFIDES analysis , *BREATH tests , *LONGITUDINAL method , *ODORS , *RESEARCH funding , *PARASITEMIA - Abstract
Currently, the majority of diagnoses of malaria rely on a combination of the patient's clinical presentation and the visualization of parasites on a stained blood film. Breath offers an attractive alternative to blood as the basis for simple, noninvasive diagnosis of infectious diseases. In this study, breath samples were collected from individuals during controlled malaria to determine whether specific malaria-associated volatiles could be detected in breath. We identified 9 compounds whose concentrations varied significantly over the course of malaria: carbon dioxide, isoprene, acetone, benzene, cyclohexanone, and 4 thioethers. The latter group, consisting of allyl methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene, and (E)-1-methylthio-1-propene, had not previously been associated with any disease or condition. Before the availability of antimalarial drug treatment, there was evidence of concurrent 48-hour cyclical changes in the levels of both thioethers and parasitemia. When thioether concentrations were subjected to a phase shift of 24 hours, a direct correlation between the parasitemia and volatile levels was revealed. Volatile levels declined monotonically approximately 6.5 hours after initial drug treatment, correlating with clearance of parasitemia. No thioethers were detected in in vitro cultures of Plasmodium falciparum. The metabolic origin of the thioethers is not known, but results suggest that interplay between host and parasite metabolic pathways is involved in the production of these thioethers. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
23. Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers.
- Author
-
McCarthy, James S., Griffin, Paul M., Sekuloski, Silvana, Bright, A. Taylor, Rockett, Rebecca, Looke, David, Elliott, Suzanne, Whiley, David, Sloots, Theo, Winzeler, Elizabeth A., and Trenholme, Katharine R.
- Subjects
- *
PLASMODIUM vivax , *MALARIA , *INFECTION , *VACCINES , *GERM cells , *ANTIMALARIALS - Abstract
Background. Major impediments to development of vaccines and drugs for Plasmodium vivax malaria are the inability to culture this species and the extreme difficulty in undertaking clinical research by experimental infection.Methods. A parasite bank was collected from a 49-year-old woman with P. vivax infection, characterized, and used in an experimental infection study.Results. The donor made a full recovery from malaria after collection of a parasite bank, which tested negative for agents screened for in blood donations. DNA sequence analysis of the isolate indicated that it was clonal. Two subjects inoculated with the isolate became polymerase chain reaction positive on days 8 and 9, with onset of symptoms and positive blood smears on day 14, when they were treated with artemether-lumefantrine, with rapid clinical and parasitologic response. Transcripts of the parasite gene pvs25 that is expressed in gametocytes, the life cycle stage infectious to mosquitoes, were first detected on days 11 and 12.Conclusions. This experimental system results in in vivo parasite growth, probably infectious to mosquitoes. It offers the opportunity to undertake studies previously impossible in P. vivax that will facilitate a better understanding of the pathology of vivax malaria and development of antimalarial drugs and vaccines.Trial Registration. ANZCTR: 12612001096842. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
24. Low-Level Plasmodium falciparum Blood-Stage Infection Causes Dendritic Cell Apoptosis and Dysfunction in Healthy Volunteers.
- Author
-
Woodberry, Tonia, Minigo, Gabriela, Piera, Kim A., Amante, Fiona H., Pinzon-Charry, Alberto, Good, Michael F., Lopez, J. Alejandro, Engwerda, Christian R., McCarthy, James S., and Anstey, Nicholas M.
- Subjects
PLASMODIUM falciparum ,DENDRITIC cells ,APOPTOSIS ,DRUG administration ,ETIOLOGY of diseases ,SYMPTOMS ,IMMUNE response - Abstract
Background. Dendritic cells (DCs) are highly specialized antigen-presenting cells that are crucial for initiation of immune responses. During naturally acquired malaria, DC number and function is reduced.Methods. The timing of, parasitemia threshold of, and contribution of apoptosis to DC loss were prospectively evaluated in 10 men after experimental challenge with approximately 1800 Plasmodium falciparum–parasitized red blood cells (pRBCs) and after drug cure initiated at a parasite level of ≥1000 parasites/mL.Results. The nadir levels of total, myeloid, and plasmacytoid DCs occurred 8 days after infection. DC loss was partially attributable to apoptosis, which was first detected on day 5 (median parasite level, 238 parasites/mL) and maximal at day 7. Remaining DCs exhibited a reduced ability to uptake particulate antigen. DC numbers recovered approximately 60 hours after antimalarial drug administration. There was no loss of DC number or function before or after drug cure in 5 men inoculated with <180 pRBCs and treated on day 6, when their parasite level was approximately 200 parasites/mL.Conclusions. Plasmodium causes DC loss in vivo, which is at least partially explained by apoptosis in response to blood-stage parasites. In primary infection, loss of DC number and function occurs early during the prepatent period and before or with onset of clinical symptoms. These findings may explain in part the inadequate development of immunity to blood-stage malaria infection. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
25. Perspective: Prospects for Development of Vaccines against Human Helminth Infections.
- Author
-
McCarthy, James S. and Nutman, Thomas B.
- Published
- 1996
- Full Text
- View/download PDF
26. Evaluation of a Polymerase Chain Reaction-Based Assay for Diagnosis of Wuchereria bancrofti Infection.
- Author
-
McCarthy, James S., Zhong, Min, Gopinath, Ramya, Ottesen, Eric A., Williams, Steven A., and Nutman, Thomas B.
- Abstract
To assess the utility of a polymerase chain reaction (PCR)-based method for diagnosis of Wuchereria bancrofti infection, blood, plasma, and paraffin-embedded tissue samples were tested using a PCR-based assay that detects a W. bancrofti-specific repetitive DNA sequence. The assay was positive in 100 µL of blood from 40 of 42 microfilaria-positive subjects, the 2 subjects with negative assays having microfilarial counts of 1. Samples from 127 uninfected subjects were PCR-negative. The assay was also positive in 7 of 10 daytime samples in regions where infection is nocturnally periodic; PCR amplification from paraffin-embedded sections established the diagnosis of W. bancrofti infection in another 2 cases. A microtiter ELISA plate-based method was developed for rapid evaluation of large numbers of samples. These results suggest that this PCR-based assay will be useful in diagnosis of W. bancrofti infection in a variety of clinical settings. [ABSTRACT FROM PUBLISHER]
- Published
- 1996
- Full Text
- View/download PDF
27. Clearance of Circulating Filarial Antigen as a Measure of the Macrofilaricidal Activity of Diethylcarbamazine in Wuchereria bancrofti Infection.
- Author
-
McCarthy, James S., Guinea, Archie, Weil, Gary J., and Ottesen, Eric A.
- Abstract
Small doses of diethylcarbamazine (DEC) clear microfilariae (MF) from the blood of Wuchereria banerofti-infected persons, but the dose and regimen required to kill adult worms is not clearly defined. A prospective study was undertaken to examine the macrofilaricidal effect of DEC and the ability of an assay for circulating filarial antigen (CFA) to define the effect. Twenty-five MF-positive subjects and 7 MF-negative but CFA-positive subjects were treated with DEC and followed for 18 months. Of the 25 MF-positive patients, 24 cleared MF, and 22 of 26 CFA-positive subjects cleared CFA. A significantly greater decrease in antifilarial IgG4 was seen in patients who cleared CFA than in those who did not. The complete clearance of CFA observed after therapy with DEC indicates that assessment of CFA clearance is a useful means for detecting macrofilaricidal effects of antifilarial chemotherapy. [ABSTRACT FROM PUBLISHER]
- Published
- 1995
- Full Text
- View/download PDF
28. Onchocerciasis In Endemic And Nonendemic Populations: Differences In Clinical Presentation And Immunologic Findings.
- Author
-
McCarthy, James S., Ottesen, Eric A., and Nutman, Thomas B.
- Abstract
To characterize the clinical and laboratory features of onchocerciasis in visitors to endemic areas and to compare them with those seen in endemic subjects, 20 returned visitors and 21 endemic subjects with onchocerciasis were evaluated. Dermatitis was the most frequent clinical finding among the returned visitors. None had nodules or eye disease and, in contrast to the endemic subjects, microfiladermia was often absent or of low density. All persons studied had antibody responses measurable by ELISA to both soluble Onchocerca volvulus antigen and a panel of diagnostic recombinant antigens. Eosinophil and IgE levels were significantly higher in the endemic group, as was the capacity of peripheral blood mononuclear cells from this group to produce the T helper cell-like cytokines interleukin-4 and -5. It is likely that the chronicity and intensity of infection in endemic subjects account for the clinical and immunologic differences observed between the 2 groups. [ABSTRACT FROM PUBLISHER]
- Published
- 1994
29. Corrigendum to: A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection.
- Author
-
Alkema, Manon, Reuling, Isaie J, Jong, Gerdie M de, Lanke, Kjerstin, Coffeng, Luc E, Gemert, Geert-Jan van, van de Vegte-Bolmer, Marga, Mast, Quirijn de, Crevel, Reinout van, Ivinson, Karen, Ockenhouse, Christian F, McCarthy, James S, Sauerwein, Robert, Collins, Katharine A, Bousema, Teun, de Jong, Gerdie M, van Gemert, Geert-Jan, de Mast, Quirijn, and van Crevel, Reinout
- Subjects
CLINICAL trials ,INFECTION control ,MOSQUITO control ,PLASMODIUM falciparum - Abstract
Corrigendum to: A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
30. A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection.
- Author
-
Alkema, Manon, Reuling, Isaie J, de Jong, Gerdie M, Lanke, Kjerstin, Coffeng, Luc E, van Gemert, Geert-Jan, van de Vegte-Bolmer, Marga, de Mast, Quirijn, van Crevel, Reinout, Ivinson, Karen, Ockenhouse, Christian F, McCarthy, James S, Sauerwein, Robert, Collins, Katharine A, and Bousema, Teun
- Abstract
Background: For malaria elimination efforts, it is important to better understand parasite transmission to mosquitoes and develop models for early-clinical evaluation of transmission-blocking interventions.Methods: In a randomized open-label trial, 24 participants were infected by bites from Plasmodium falciparum 3D7-infected mosquitoes (mosquito bite [MB]; n = 12) or by induced blood-stage malaria (IBSM) with the same parasite line (n = 12). After subcurative piperaquine treatment, asexual parasite and gametocytes kinetics were assessed, and mosquito feeding experiments were performed.Results: Study procedures were well tolerated. The median peak gametocyte density was 1304/mL (interquartile range, 308-1607/mL) after IBSM, compared with 14/mL (10-64/mL) after MB inoculation (P < .001), despite similar peak asexual parasite densities (P = .48). Peak gametocyte density was correlated with preceding pfap2-g transcripts, indicative of gametocyte commitment (ρ = 0.62; P = .002). Direct feeding assays resulted in mosquito infections from 9 of 12 participants after IBSM versus 0 of 12 after MB inoculation (P < .001).Conclusions: We observed a striking effect of inoculation method on gametocyte production, suggesting higher gametocyte commitment after IBSM. Our direct comparison of MB and IBSM establishes the controlled human malaria infection transmission model, using intravenous administration of P. falciparum-infected erythrocytes as a model for early-clinical evaluation of interventions that aim to interrupt malaria transmission.Clinical Trial Registration: NCT03454048. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
31. Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.
- Author
-
Loughland, Jessica R, Woodberry, Tonia, Boyle, Michelle J, Tipping, Peta E, Piera, Kim A, Amante, Fiona H, Kenangalem, Enny, Price, Ric N, Engwerda, Christian R, Anstey, Nicholas M, McCarthy, James S, and Minigo, Gabriela
- Abstract
Background: The malaria causing parasite Plasmodium subverts host immune responses by several strategies including the modulation of dendritic cells (DCs).Methods: In this study, we show that Plasmodium falciparum skewed CD16+ DC cytokine responses towards interleukin (IL)-10 production in vitro, distinct to the cytokine profile induced by Toll-like receptor ligation. To determine CD16+ DC responsiveness in vivo, we assessed their function after induced P falciparum infection in malaria-naive volunteers.Results: CD16+ DCs underwent distinctive activation, with increased expression of maturation markers human leukocyte antigen (HLA)-DR and CD86, enhanced tumor necrosis factor (TNF) production, and coproduction of TNF/IL-10. In vitro restimulation with P falciparum further increased IL-10 production. In contrast, during naturally acquired malaria episode, CD16+ DCs showed diminished maturation, suggesting increased parasite burden and previous exposure influence DC subset function.Conclusions: These findings identify CD16+ DCs as the only DC subset activated during primary blood-stage human Plasmodium infection. As dual cytokine producers, CD16+ DCs contribute to inflammatory as well as regulatory innate immune processes. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
32. Molecular methods enhance the detection of pyoderma-related Streptococcus pyogenes and emm-type distribution in children.
- Author
-
Hall JN, Armitage EP, Senghore E, Darboe S, Barry M, Camara J, Bah S, Keeley AJ, McCarthy JS, Smeesters P, Turner CE, Darton TC, Marks M, Angyal A, and de Silva TI
- Abstract
Background: Streptococcus pyogenes-related skin infections are increasingly implicated in the development of rheumatic heart disease (RHD) in lower-resourced settings, where they are often associated with scabies. The true prevalence of S. pyogenes-related pyoderma may be underestimated by bacterial culture., Methods: A multiplex qPCR for S. pyogenes, Staphylococcus aureus and Sarcoptes scabiei was applied to 250 pyoderma swabs from a cross-sectional study of children <5 years in The Gambia. Direct PCR-based emm-typing was used to supplement previous whole genome sequencing (WGS) of cultured isolates., Results: Pyoderma lesions with S. pyogenes increased from 51% (127/250) using culture to 80% (199/250) with qPCR. Compared to qPCR, the sensitivity of culture was 95.4% for S. pyogenes (95% CI 77.2-99.9) in samples with S. pyogenes alone (22/250, 9%), but 59.9% (95% CI 52.3-67.2) for samples with S. aureus co-infection (177/250, 71%). Direct PCR-based emm-typing was successful in 50% (46/92) of cases, identifying 27 emm-types, including six not identified by WGS (total 52 emm-types)., Conclusions: Bacterial culture significantly underestimates the burden of S. pyogenes in pyoderma, particularly when co-infected with S. aureus. Molecular methods should be used to enhance the detection of S. pyogenes in surveillance studies and clinical trials of preventative measures in RHD-endemic settings., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
33. A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite-Induced Controlled Malaria Infection.
- Author
-
Alkema M, Reuling IJ, de Jong GM, Lanke K, Coffeng LE, van Gemert GJ, van de Vegte-Bolmer M, de Mast Q, van Crevel R, Ivinson K, Ockenhouse CF, McCarthy JS, Sauerwein R, Collins KA, and Bousema T
- Subjects
- Adolescent, Animals, Female, Humans, Malaria, Malaria, Falciparum drug therapy, Malaria, Falciparum parasitology, Malaria, Falciparum transmission, Male, Parasitemia, Anopheles parasitology, Insect Bites and Stings, Malaria, Falciparum blood, Plasmodium falciparum isolation & purification
- Abstract
Background: For malaria elimination efforts, it is important to better understand parasite transmission to mosquitoes and develop models for early-clinical evaluation of transmission-blocking interventions., Methods: In a randomized open-label trial, 24 participants were infected by bites from Plasmodium falciparum 3D7-infected mosquitoes (mosquito bite [MB]; n = 12) or by induced blood-stage malaria (IBSM) with the same parasite line (n = 12). After subcurative piperaquine treatment, asexual parasite and gametocytes kinetics were assessed, and mosquito feeding experiments were performed., Results: Study procedures were well tolerated. The median peak gametocyte density was 1304/mL (interquartile range, 308-1607/mL) after IBSM, compared with 14/mL (10-64/mL) after MB inoculation (P < .001), despite similar peak asexual parasite densities (P = .48). Peak gametocyte density was correlated with preceding pfap2-g transcripts, indicative of gametocyte commitment (ρ = 0.62; P = .002). Direct feeding assays resulted in mosquito infections from 9 of 12 participants after IBSM versus 0 of 12 after MB inoculation (P < .001)., Conclusions: We observed a striking effect of inoculation method on gametocyte production, suggesting higher gametocyte commitment after IBSM. Our direct comparison of MB and IBSM establishes the controlled human malaria infection transmission model, using intravenous administration of P. falciparum-infected erythrocytes as a model for early-clinical evaluation of interventions that aim to interrupt malaria transmission., Clinical Trial Registration: NCT03454048., (© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2021
- Full Text
- View/download PDF
34. Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.
- Author
-
Loughland JR, Woodberry T, Boyle MJ, Tipping PE, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, and Minigo G
- Subjects
- Adult, Child, Dendritic Cells chemistry, Female, GPI-Linked Proteins analysis, Humans, Malaria, Falciparum, Male, Receptors, IgG analysis, Young Adult, Dendritic Cells immunology, Interleukin-10 metabolism, Plasmodium falciparum immunology, Tumor Necrosis Factor-alpha metabolism
- Abstract
Background: The malaria causing parasite Plasmodium subverts host immune responses by several strategies including the modulation of dendritic cells (DCs)., Methods: In this study, we show that Plasmodium falciparum skewed CD16+ DC cytokine responses towards interleukin (IL)-10 production in vitro, distinct to the cytokine profile induced by Toll-like receptor ligation. To determine CD16+ DC responsiveness in vivo, we assessed their function after induced P falciparum infection in malaria-naive volunteers., Results: CD16+ DCs underwent distinctive activation, with increased expression of maturation markers human leukocyte antigen (HLA)-DR and CD86, enhanced tumor necrosis factor (TNF) production, and coproduction of TNF/IL-10. In vitro restimulation with P falciparum further increased IL-10 production. In contrast, during naturally acquired malaria episode, CD16+ DCs showed diminished maturation, suggesting increased parasite burden and previous exposure influence DC subset function., Conclusions: These findings identify CD16+ DCs as the only DC subset activated during primary blood-stage human Plasmodium infection. As dual cytokine producers, CD16+ DCs contribute to inflammatory as well as regulatory innate immune processes.
- Published
- 2019
- Full Text
- View/download PDF
35. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
- Author
-
Payne RO, Milne KH, Elias SC, Edwards NJ, Douglas AD, Brown RE, Silk SE, Biswas S, Miura K, Roberts R, Rampling TW, Venkatraman N, Hodgson SH, Labbé GM, Halstead FD, Poulton ID, Nugent FL, de Graaf H, Sukhtankar P, Williams NC, Ockenhouse CF, Kathcart AK, Qabar AN, Waters NC, Soisson LA, Birkett AJ, Cooke GS, Faust SN, Woods C, Ivinson K, McCarthy JS, Diggs CL, Vekemans J, Long CA, Hill AV, Lawrie AM, Dutta S, and Draper SJ
- Subjects
- Adult, Enzyme-Linked Immunospot Assay, Erythrocytes parasitology, Female, Humans, Immunogenicity, Vaccine, Life Cycle Stages, Malaria, Falciparum parasitology, Male, Middle Aged, Models, Biological, Plasmodium falciparum physiology, Young Adult, Antigens, Protozoan immunology, Malaria Vaccines immunology, Malaria, Falciparum prevention & control, Membrane Proteins immunology, Plasmodium falciparum immunology, Protozoan Proteins immunology
- Abstract
Background: Models of controlled human malaria infection (CHMI) initiated by mosquito bite have been widely used to assess efficacy of preerythrocytic vaccine candidates in small proof-of-concept phase 2a clinical trials. Efficacy testing of blood-stage malaria parasite vaccines, however, has generally relied on larger-scale phase 2b field trials in malaria-endemic populations. We report the use of a blood-stage P. falciparum CHMI model to assess blood-stage vaccine candidates, using their impact on the parasite multiplication rate (PMR) as the primary efficacy end point., Methods: Fifteen healthy United Kingdom adult volunteers were vaccinated with FMP2.1, a protein vaccine that is based on the 3D7 clone sequence of apical membrane antigen 1 (AMA1) and formulated in Adjuvant System 01 (AS01). Twelve vaccinees and 15 infectivity controls subsequently underwent blood-stage CHMI. Parasitemia was monitored by quantitative real-time polymerase chain reaction (PCR) analysis, and PMR was modeled from these data., Results: FMP2.1/AS01 elicited anti-AMA1 T-cell and serum antibody responses. Analysis of purified immunoglobulin G showed functional growth inhibitory activity against P. falciparum in vitro. There were no vaccine- or CHMI-related safety concerns. All volunteers developed blood-stage parasitemia, with no impact of the vaccine on PMR., Conclusions: FMP2.1/AS01 demonstrated no efficacy after blood-stage CHMI. However, the model induced highly reproducible infection in all volunteers and will accelerate proof-of-concept testing of future blood-stage vaccine candidates., Clinical Trials Registration: NCT02044198., (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.